BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12569606)

  • 1. Detection of tumor specific gene expression in bone marrow and peripheral blood from patients with small cell lung carcinoma.
    Shingyoji M; Takiguchi Y; Watanabe R; Hiroshima K; Motoori K; Kurosu K; Kasahara Y; Tanabe N; Tatsumi K; Kuriyama T
    Cancer; 2003 Feb; 97(4):1057-62. PubMed ID: 12569606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
    Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
    Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by reverse transcriptase-polymerase chain reaction.
    Bessho A; Tabata M; Kiura K; Takata I; Nagata T; Fujimoto N; Kunisada K; Ueoka H; Harada M
    Anticancer Res; 2000; 20(2B):1149-54. PubMed ID: 10810412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
    Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.
    Cardona C; Rabbitts PH; Spindel ER; Ghatei MA; Bleehen NM; Bloom SR; Reeve JG
    Cancer Res; 1991 Oct; 51(19):5205-11. PubMed ID: 1717141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant protein gene expressions for detection of lung carcinoma cells in peripheral blood.
    Yamamoto O; Takahashi H; Hirasawa M; Chiba H; Shiratori M; Kuroki Y; Abe S
    Respir Med; 2005 Sep; 99(9):1164-74. PubMed ID: 16085219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
    Siegfried JM; Krishnamachary N; Gaither Davis A; Gubish C; Hunt JD; Shriver SP
    Pulm Pharmacol Ther; 1999; 12(5):291-302. PubMed ID: 10545285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer.
    Sienel W; Mecklenburg I; Dango S; Ehrhardt P; Kirschbaum A; Passlick B; Pantel K
    Clin Cancer Res; 2007 Jul; 13(13):3840-7. PubMed ID: 17606715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of diagnosing micrometastasis by nested RT-PCR in the peripheral blood and bone marrow in non-small cell lung cancer patients].
    Zhou QH; Gong YL; Qin Y; Sun ZL; Sun ZF; Liu LX; Li L; Zhu W
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):62-5. PubMed ID: 12678991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ewing tumor family of peripheral primitive neuroectodermal tumors expresses human gastrin-releasing peptide.
    Lawlor ER; Lim JF; Tao W; Poremba C; Chow CJ; Kalousek IV; Kovar H; MacDonald TJ; Sorensen PH
    Cancer Res; 1998 Jun; 58(11):2469-76. PubMed ID: 9622091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by promoter methylation and silencing of the retinoic acid receptor-beta.
    Oshita F; Sekiyama A; Suzuki R; Ikehara M; Yamada K; Saito H; Noda K; Miyagi Y
    Oncol Rep; 2003; 10(1):105-8. PubMed ID: 12469153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer.
    Chen LC; Brown AB; Cheung IY; Cheung NK; Kris MG; Krug LM
    Lung Cancer; 2010 Feb; 67(2):216-20. PubMed ID: 19457569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.
    Okusaka T; Eguchi K; Kasai T; Kurata T; Yamamoto N; Ohe Y; Tamura T; Shinkai T; Saijo N
    Clin Cancer Res; 1997 Jan; 3(1):123-7. PubMed ID: 9815547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancer.
    Oremek GM; Sapoutzis N
    Anticancer Res; 2003; 23(2A):895-8. PubMed ID: 12820319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.
    Aguayo SM; Miller Y; Boose D; Holley M; Portanova LB; Schuyler KD; Kane MA
    Cell Growth Differ; 1996 May; 7(5):563-72. PubMed ID: 8732666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCR.
    Lacroix J; Becker HD; Woerner SM; Rittgen W; Drings P; von Knebel Doeberitz M
    Int J Cancer; 2001 Apr; 92(1):1-8. PubMed ID: 11279599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.
    Mimori K; Fukagawa T; Kosaka Y; Ishikawa K; Iwatsuki M; Yokobori T; Hirasaki S; Takatsuno Y; Sakashita H; Ishii H; Sasako M; Mori M
    Ann Surg Oncol; 2008 Oct; 15(10):2934-42. PubMed ID: 18661187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
    Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
    Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
    Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.